NovAccess Global Inc.

NovAccess Global Inc. Share · US67001N1072 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of NovAccess Global Inc.
No Price
Closing Price OTC 30.04.2026: 0,0001 USD
30.04.2026 20:00
Current Prices from NovAccess Global Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
XSNX
USD
30.04.2026 20:00
0,0001 USD
0,00 USD
Company Profile for NovAccess Global Inc. Share
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.

Company Data

Name NovAccess Global Inc.
Company NovAccess Global Inc.
Website https://novaccessglobal.com
Primary Exchange OTC UTC
ISIN US67001N1072
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dwain K. Morris-Irvin M.P.H., MPH,
Country United States of America
Currency USD
Employees 0,0 T
Address 8834 Mayfield Road, 44026 Chesterland
IPO Date 1998-09-21

Stock Splits

Date Split
26.08.2020 1:1000
07.10.2003 1:20

Ticker Symbols

Name Symbol
Over The Counter XSNX
More Shares
Investors who hold NovAccess Global Inc. also have the following shares in their portfolio:
FDC International Hotels Corporation
FDC International Hotels Corporation Share
RAIF.BK INT. 23/28 FLRMTN
RAIF.BK INT. 23/28 FLRMTN Bond